Dear visitor,
QIAGEN has decided to discontinue its Genomic Services offering following a comprehensive strategic review. We will continue to support all current customer project orders during the transition period through April 2026.
Throughout the transition, customers with active projects will continue to have access to customer support, project management and required deliverables for a defined period. We will also provide guidance to help customers transition projects to alternative solutions where needed.
This change does not affect the availability of custom-designed dPCR and qPCR assays. For further information, please get in touch with your local QIAGEN sales representative.
We thank you for your continued support and understanding.
QIAGEN Genomic Services Team